Nationwide
A Phase 3B Trial to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
Ph 3·~7yr·120 sites in AL, AZ, CA +24
Sumitomo Pharma Switzerland GmbH
Mayo Clinic
Medtronic - MITG
Yale University
Samphire Group, Inc.
Main Line Health
University of California, San Diego
Penn State University
Penn State University
Milton S. Hershey Medical Center
Hera Biotech, Inc.
Mclean Hospital
University of North Carolina, Chapel Hill
Boston Children's Hospital
Washington University School of Medicine
Oregon Health and Science University
TriHealth Inc.
Baylor College of Medicine
Physicians Committee for Responsible Medicine